In Vivo is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

Brought to you by

CardioMEMS gets $33mm through its Series E round

Executive Summary

CardioMEMS (wireless medical devices used in the management of cardiovascular diseases) has raised $33mm through the closing of its Series E venture round. Arcapita Ventures led the financing and was joined by current backers Boston Millennia Partners, Medtronic, Easton Capital Partners, Foundation Medical Partners, Johnson & Johnson Development Corp., and Arboretum Ventures as well as new investors Deerfield Capital Management, Vision Capital Advisors, Aperture Venture Partners, and Rockport Venture Securities.
Deal Industry
  • Medical Devices
  • Medical Devices
    • Diagnostic Equipment & Supplies
    • Implantable Devices
    • Monitoring Equipment & Devices
Deal Status
  • Final
Deal Type
  • Financing
    • Venture Financing

Related Companies